Eagle Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three
Eagle Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Three of $0 as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2023-08-09
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $0.00.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $0.00.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $413.00K.
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $413.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three |
|---|---|
| 2023-06-30 | $0.00 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $413.00K 10-K · filed 2023-03-23 |
| 2022-09-30 | $413.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $413.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $413.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.04M 10-K · filed 2022-03-08 |
| 2021-09-30 | $1.04M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.04M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.04M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.46M 10-K · filed 2021-03-05 |
| 2020-09-30 | $1.29M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $1.29M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.38M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.38M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $1.36M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $583.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $583.00K 10-Q · filed 2019-05-07 |